IMI2-2018-16-01
IMI2-2018-16-01
1 project · €6,840,000 total EU contribution (project-level) · 9 participating organizations · 5 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€6,840,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (3)
- BE (2)
- France (2)
- AT (1)
- DK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Leiden University Medical Center1 projects · NL
- FFUND BV1 projects · NL
- JANSSEN PHARMACEUTICA NV1 projects · BE
- UCPH1 projects · DK
- MEDIZINISCHE UNIVERSITAET WIEN1 projects · AT
- MITOLOGICS1 projects · FR
- SORBONNE UNIVERSITE1 projects · FR
- UANTWERPEN1 projects · BE
- ULEI1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors RespiriTB · 853903 | H2020 | €6,840,000 | €638,375 | Details |